EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)

Gene Therapy in Patients with the Crigler–Najjar Syndrome

Lorenzo D'Antiga, Ulrich Beuers, Giuseppe Ronzitti, Nicola Brunetti-Pierri, Ulrich Baumann, Angelo Di Giorgio, Sem Aronson, Aurelie Hubert, Roberta Romano, Norman Junge, Piter Bosma, Giulia Bortolussi und 7 weitere

New England Journal of Medicine · 17.08.2023 · 389 (7) · 620-631

DOI: 10.1056/nejmoa2214084 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 17.08.2023. Verfasst von Lorenzo D'Antiga und 18 weiteren Autor:innen. Beteiligte Einrichtung: From Department of Pediatric Hepatology, Gastroenterology, and Transplantation, Hospital Papa Giovanni XXIII, Bergamo (L.D., A.D.G.), Scuola Superior…. Hauptthemen laut MEDLINE: Crigler-Najjar Syndrome, Genetic Therapy, Glucuronosyltransferase. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme, Genethon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crigler-Najjar SyndromeGenetic TherapyGlucuronosyltransferaseHumansAdministration, IntravenousBilirubinDependovirusGenetic VectorsHyperbilirubinemiaLiver TransplantationPhototherapyUGT1A1 Enzyme

Substanzen

BilirubinGlucuronosyltransferaseUGT1A1 Enzyme

Autor:innen und Institutionen

  • From Department of Pediatric Hepatology, Gastroenterology, and Transplantation, Hospital Papa Giovanni XXIII, Bergamo (L.D., A.D.G.), Scuola Superiore Meridionale, Genomics and Experimental Medicine Program (N.B.-P.), D…

ORCID-Profile: Andrés F Muro

Förderung

  • Horizon 2020 Framework Programme
  • Genethon

Zitieren

APA

D'Antiga, L., Beuers, U., Ronzitti, G., Brunetti-Pierri, N., Baumann, U., Di Giorgio, A., Aronson, S., Hubert, A., Romano, R., Junge, N., Bosma, P., Bortolussi, G., Muro, A. F., Soumoudronga, R. F., Veron, P., Collaud, F., Knuchel-Legendre, N., Labrune, P., & Mingozzi, F. (2023). Gene Therapy in Patients with the Crigler–Najjar Syndrome. New England Journal of Medicine, 389(7), 620-631. https://doi.org/10.1056/nejmoa2214084

Vancouver

D'Antiga L, Beuers U, Ronzitti G, Brunetti-Pierri N, Baumann U, Di Giorgio A, et al. Gene Therapy in Patients with the Crigler–Najjar Syndrome. New England Journal of Medicine. 2023;389(7):620-631. doi:10.1056/nejmoa2214084

BibTeX
@article{DAntiga2023,
  author = {D'Antiga, Lorenzo and Beuers, Ulrich and Ronzitti, Giuseppe and Brunetti-Pierri, Nicola and Baumann, Ulrich and Di Giorgio, Angelo and Aronson, Sem and Hubert, Aurelie and Romano, Roberta and Junge, Norman and Bosma, Piter and Bortolussi, Giulia and Muro, Andrés F and Soumoudronga, Ravaka F and Veron, Philippe and Collaud, Fanny and Knuchel-Legendre, Nathalie and Labrune, Philippe and Mingozzi, Federico},
  title = {Gene Therapy in Patients with the Crigler–Najjar Syndrome},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {7},
  pages = {620--631},
  doi = {10.1056/nejmoa2214084}
}
Kostenlos starten →